Clinical Trials
11 trialsNCT05311618 2024-04-01
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Phase 1 Unknown
NCT06307093 2024-03-12
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
Phase 1 Unknown
NCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
NCT04670445 2023-10-23
UPLIFT
Massachusetts General Hospital
Phase NA Unknown
NCT05685524 2023-01-17
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Unknown
NCT05505877 2022-08-18
Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors
Shanghai Gopherwood Biotech Co., Ltd.
Phase 1/2 Unknown
NCT05117138 2021-11-11
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1/2 Unknown
NCT02433626 2019-02-01
COTI2-101
Critical Outcome Technologies Inc.
Phase 1 Unknown
NCT03076372 2018-02-27
A Study Evaluating MM-310 in Patients With Solid Tumors
Merrimack Pharmaceuticals
Phase 1 Unknown
NCT00122239 2016-03-16
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
AHS Cancer Control Alberta
Unknown
NCT00637637 2013-08-12
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Phase 2 Unknown